Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 08, 2026 07:01 ET | Source: Purdue Research Foundation

Software from tech startup Leto helps caseworkers connect clients with community resources

WEST LAFAYETTE, Ind., April 08, 2026 (GLOBE NEWSWIRE) -- Professionals at federally qualified health centers, mental health centers, social service agencies, hospitals, institutes of higher...
April 07, 2026 13:47 ET | Source: Methodist Healthcare Ministries of South Texas, Inc.

MHM Invests $237.5 Million to Create a Healthier Future Across South Texas

San Antonio, TX, April 07, 2026 (GLOBE NEWSWIRE) -- Methodist Healthcare Ministries of South Texas, Inc. (MHM) is investing $237.5 million in 2026 — an 11 percent increase over its 2025 commitment —...
April 07, 2026 13:19 ET | Source: Natural Remedies

Natural Remedies Awarded American Botanical Council’s 2026 Varro E. Tyler Commercial Investment in Phytomedicinal Research Award

American Botanical Council presented Natural Remedies with the 2026 ABC Varro E. Tyler Commercial Investment in Phytomedicinal Research Award.
April 07, 2026 09:00 ET | Source: Manatt, Phelps & Phillips, LLP

Manatt Deepens Health Tech, AI and Innovation Capabilities with Senior Advisor in Boston

Former CMMI Chief Informatics Officer and physician Will Gordon brings deep experience at the intersection of clinical care, health policy and enterprise technology BOSTON, April 07, 2026 (GLOBE...
April 07, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Communiqué de presse: Le lunsekimig de Sanofi a atteint les critères d’évaluation principal et secondaires clés dans les études respiratoires de phase 2 dans l’asthme et la rhinosinusite chronique avec polypose nasale

Des études de phase 2 sur le lunsekimig ont atteint les critères d’évaluation principaux et secondaires clés dans deux maladies respiratoires
April 07, 2026 01:00 ET | Source: Sanofi Winthrop Industrie

Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP

Phase 2 studies of lunsekimig, a novel bispecific nanobody, met primary and key secondary endpoints in two chronic respiratory conditions.
April 06, 2026 17:38 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Urgently Reminds Investors that a Class Action Lawsuit Has Been Filed Against Inovio Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm Before April 7th

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Inovio (INO) To Contact Him Directly To Discuss Their Options If you purchased or...
April 06, 2026 14:00 ET | Source: BCC Research LLC

Global Validation, Calibration and Standardization in Life Sciences Market to Reach $3.9 Billion by 2030, Fueled by Regulatory Demands and Digital Transformation

Increasing regulatory requirements and the need for data accuracy are driving demand for validation, calibration, and standardization in life sciences.
April 04, 2026 11:21 ET | Source: ThinkCareBelieve

ThinkCareBelieve: Week 63 of the Trump 2.0 Administration

Week 63 of President Trump's Second Term. The article highlights events that took place in America- can be used as a reference, a resource or review.
April 03, 2026 13:02 ET | Source: Bragar Eagel & Squire

BLACKROCK TCP DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urgently Reminds BlackRock TCP Investors with Large Losses to Contact the Firm Before April 6th

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In BlackRock TCP (TCPC) To Contact Him Directly To Discuss Their Options If you purchased or...